Cancer drugs linked to bone changes doctors may miss on X-rays

Researchers have identified radiographic patterns in cancer patients taking bone-protective medications that radiologists might overlook or misinterpret. The findings could improve diagnostic accuracy and patient safety monitoring in a growing population of long-term cancer survivors on antiresorptive therapy.

Originaltitel: Radiographic perception of anatomical structures and bony changes in oncologic patients under antiresorptive therapy